483
Baxalta US IncorporatedBaxalta US Incorporated – FDA 483
Record Details
An FDA inspection of Baxalta US Inc. in Los Angeles, CA, a blood fractionation manufacturing facility, identified two observations related to quality control. The firm failed to repeat environmental monitoring performance qualification studies and a washer study, despite these studies not meeting their predefined acceptance criteria. This indicates a deficiency in ensuring the validity and reliability of critical manufacturing processes.
- Company
- Baxalta US Incorporated
- Product type
- biologics
View Company Profile
ID · 2c9f53ea-4178-44bd-9dff-97e8db87c69b
Other documents for Baxalta US Incorporated
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.